Related Experiment Video
Updated: Jul 29, 2025

09:23
Parasite Induced Genetically Driven Autoimmune Chagas Heart Disease in the Chicken Model
Published on: July 29, 2012
14.0K
Chagas Disease Cardiomyopathy.
Dimensions of Critical Care Nursing : DCCN
|May 23, 2023
Summary
Chagas cardiomyopathy, a severe heart failure complication, requires critical care nurses to understand its unique aspects. This overview details its clinical course, management, and treatment for better patient care.
Area of Science:
- Tropical Medicine
- Cardiology
- Infectious Diseases
Background:
- Chagas disease is a significant neglected tropical disease in Latin America.
- Chagas cardiomyopathy, a severe manifestation, leads to heart failure.
- Globalization increases Chagas cardiomyopathy cases in the United States.
Purpose of the Study:
- Educate critical care nurses on Chagas cardiomyopathy.
- Differentiate Chagas cardiomyopathy from ischemic and nonischemic forms.
- Provide an overview of clinical course, management, and treatment.
Main Methods:
- Literature review of Chagas cardiomyopathy.
- Analysis of clinical presentations.
- Summary of current management strategies.
Main Results:
- Chagas cardiomyopathy presents unique challenges in critical care.
- Understanding its distinct pathophysiology is crucial for effective management.
- Treatment requires a multidisciplinary approach.
Conclusions:
- Critical care nurses need specialized knowledge of Chagas cardiomyopathy.
- Early recognition and appropriate management improve patient outcomes.
- Further research is needed to optimize treatment protocols.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
12
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
12
Cardiomyopathy III: Hypertrophic Cardiomyopathy
17
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
17
Cardiomyopathy I: Introduction and Classification
25
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
25
Cardiomyopathy IV: Restrictive Cardiomyopathy
12
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
12
Cardiomyopathy VI: Nursing Management
19
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
19
Cardiomyopathy V: Interprofessional Care
19
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
19

